HOME >> BIOLOGY >> NEWS
Is there a common genetic link for depression and cardiovascular disease?

A large body of evidence has emerged over several years for an association between depressive disorder and cardiovascular disease. Although many studies have shown that depression increases the risk for coronary artery disease and the mortality rates after myocardial infarction, there is recent support for the assumption that the relation between both disorders may be bi-directional. The mechanisms of this interaction are at present uncertain and several factors, including stress with its multiple actions on brain and peripheral organs, acute inflammatory reactions with altered immune function as well as a genetically driven susceptibility to develop the disorders are under debate.

Regarding the genetic contribution, variants in two genes were repeatedly discussed as important predisposing factor for cardiovascular function and disease. The gene coding for the angiotensin-converting-enzyme (ACE), an enzyme which is involved in the development of hypertension and other cardiovascular distress, has a common mutation (allele-D) which results in increased ACE concentration (consequently, ACE inhibitors are used as antihypertensive agents). Several studies have shown an association between this allele-D and cardiovascular disorders, supporting the hypothesis of a genetic contribution. However, not only the actual concentration of ACE but also other factors are relevant for cardiovascular function and the development of diseases. Among those is the transduction of nervous signals, which is regulated by various components, including G-proteins. G-proteins are located within the cellular membranes and are thus key elements for the signal transduction, as they induce a cascade of cell reactions after the incoming signal. Thus alterations in the function of these G-proteins could have tremendous effects upon rapidity and quality of the nervous signal transmission. And recently a mutation in one subtype of these G-protein genes, the G-3 subunit allele-T was observed n
'"/>

Contact: Aimee Midei
molecularpsychiatry@mednet.ucla.edu
310-206-6739
Molecular Psychiatry
9-Dec-2002


Page: 1 2 3

Related biology news :

1. Waiter, theres a shark in my soup
2. Is there a benefit to having been vaccinated against smallpox as a child?
3. Is there an unexpected price for late night high tech excitement?
4. Just how many species are there, anyway?
5. Rainforests at risk: Where theres smoke, theres even more fire
6. Is there a link between soy formula and attention deficit disorder?
7. The nanoscience of wood structure Nature was there first
8. Where theres fire
9. The new biology of rocks: Are there medical implications of geomicrobiology?
10. Is there a link between alcohol and allergies?
11. Is there a protective gene against alcoholism?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology:
Cached News: